BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26266492)

  • 1. Residual CTAB Ligands as Mass Spectrometry Labels to Monitor Cellular Uptake of Au Nanorods.
    García I; Henriksen-Lacey M; Sánchez-Iglesias A; Grzelczak M; Penadés S; Liz-Marzán LM
    J Phys Chem Lett; 2015 Jun; 6(11):2003-8. PubMed ID: 26266492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stabilization and targeting of surfactant-synthesized gold nanorods.
    Rostro-Kohanloo BC; Bickford LR; Payne CM; Day ES; Anderson LJ; Zhong M; Lee S; Mayer KM; Zal T; Adam L; Dinney CP; Drezek RA; West JL; Hafner JH
    Nanotechnology; 2009 Oct; 20(43):434005. PubMed ID: 19801751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTAB-coated gold nanorods elicit allergic response through degranulation and cell death in human basophils.
    Cheung KL; Chen H; Chen Q; Wang J; Ho HP; Wong CK; Kong SK
    Nanoscale; 2012 Aug; 4(15):4447-9. PubMed ID: 22699707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detoxification of gold nanorods by conjugation with thiolated poly(ethylene glycol) and their assessment as SERS-active carriers of Raman tags.
    Boca SC; Astilean S
    Nanotechnology; 2010 Jun; 21(23):235601. PubMed ID: 20463383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes.
    Lau IP; Chen H; Wang J; Ong HC; Leung KC; Ho HP; Kong SK
    Nanotoxicology; 2012 Dec; 6():847-56. PubMed ID: 22022996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodide in CTAB prevents gold nanorod formation.
    Smith DK; Miller NR; Korgel BA
    Langmuir; 2009 Aug; 25(16):9518-24. PubMed ID: 19413325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular uptake behaviour, photothermal therapy performance, and cytotoxicity of gold nanorods with various coatings.
    Zhu XM; Fang C; Jia H; Huang Y; Cheng CH; Ko CH; Chen Z; Wang J; Wang YX
    Nanoscale; 2014 Oct; 6(19):11462-72. PubMed ID: 25155843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats.
    Lankveld DP; Rayavarapu RG; Krystek P; Oomen AG; Verharen HW; van Leeuwen TG; De Jong WH; Manohar S
    Nanomedicine (Lond); 2011 Feb; 6(2):339-49. PubMed ID: 21385136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic evaluation of gold nanorods using Allium cepa test.
    Rajeshwari A; Roy B; Chandrasekaran N; Mukherjee A
    Plant Physiol Biochem; 2016 Dec; 109():209-219. PubMed ID: 27744263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand customization and DNA functionalization of gold nanorods via round-trip phase transfer ligand exchange.
    Wijaya A; Hamad-Schifferli K
    Langmuir; 2008 Sep; 24(18):9966-9. PubMed ID: 18717601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of silver ions adsorbed on gold nanorods: surface analysis by using surface-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Niidome Y; Nakamura Y; Honda K; Akiyama Y; Nishioka K; Kawasaki H; Nakashima N
    Chem Commun (Camb); 2009 Apr; (13):1754-6. PubMed ID: 19294285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ionic strength and surfactant concentration on electrostatic surfacial assembly of cetyltrimethylammonium bromide-capped gold nanorods on fully immersed glass.
    Ferhan AR; Guo L; Kim DH
    Langmuir; 2010 Jul; 26(14):12433-42. PubMed ID: 20557083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of CTAB with peptidic ligands at the surface of gold nanorods and their self-assembling properties.
    Hamon C; Bizien T; Artzner F; Even-Hernandez P; Marchi V
    J Colloid Interface Sci; 2014 Jun; 424():90-7. PubMed ID: 24767503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid stabilized gold nanorods: towards improved colloidal stability and biocompatibility.
    Santhosh PB; Thomas N; Sudhakar S; Chadha A; Mani E
    Phys Chem Chem Phys; 2017 Jul; 19(28):18494-18504. PubMed ID: 28682382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of cetyltrimethylammonium bromide to enhance the biocompatibility of Au nanorods synthesized by a modified seed mediated growth process.
    Choi BS; Iqbal M; Lee T; Kim YH; Tae G
    J Nanosci Nanotechnol; 2008 Sep; 8(9):4670-4. PubMed ID: 19049082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and equilibrium effects of the surface passivant on the stability of Au nanorods.
    Merrill NA; Sethi M; Knecht MR
    ACS Appl Mater Interfaces; 2013 Aug; 5(16):7906-14. PubMed ID: 23919564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodide impurities in hexadecyltrimethylammonium bromide (CTAB) products: lot-lot variations and influence on gold nanorod synthesis.
    Rayavarapu RG; Ungureanu C; Krystek P; van Leeuwen TG; Manohar S
    Langmuir; 2010 Apr; 26(7):5050-5. PubMed ID: 20205463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTAB promoted synthesis of Au nanorods--temperature effects and stability considerations.
    Becker R; Liedberg B; Käll PO
    J Colloid Interface Sci; 2010 Mar; 343(1):25-30. PubMed ID: 19954787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the cellular uptake of gold nanorods.
    Huff TB; Hansen MN; Zhao Y; Cheng JX; Wei A
    Langmuir; 2007 Feb; 23(4):1596-9. PubMed ID: 17279633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Ligand Exchange Process on Gold Nanorods by Using Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Kim SW; Kim YW; Seo TH; Kim YK
    Materials (Basel); 2022 Jun; 15(13):. PubMed ID: 35806530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.